HIV-1 MN #1922 is a gp120-region peptide used to examine antigenic surface motifs in MN-strain envelope proteins. Its sequence supports mapping of loop flexibility and β-edge transitions. Researchers investigate folding to identify key recognition residues. The peptide enhances fine-scale virology research.
CAT No: H09811
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.